Your browser is no longer supported. Please, upgrade your browser.
Settings
BSTC BioSpecifics Technologies Corp. daily Stock Chart
BSTC [NASD]
BioSpecifics Technologies Corp.
Index- P/E20.16 EPS (ttm)2.79 Insider Own1.10% Shs Outstand7.49M Perf Week-3.49%
Market Cap420.71M Forward P/E13.63 EPS next Y4.12 Insider Trans-43.54% Shs Float5.34M Perf Month-15.09%
Income20.50M PEG0.92 EPS next Q0.72 Inst Own60.30% Short Float6.08% Perf Quarter-18.90%
Sales34.00M P/S12.37 EPS this Y61.10% Inst Trans-1.22% Short Ratio4.72 Perf Half Y-8.71%
Book/sh14.05 P/B4.00 EPS next Y37.33% ROA- Target Price85.00 Perf Year36.17%
Cash/sh11.28 P/C4.98 EPS next 5Y22.00% ROE- 52W Range40.58 - 73.31 Perf YTD-7.31%
Dividend- P/FCF- EPS past 5Y29.10% ROI19.10% 52W High-21.68% Beta1.25
Dividend %- Quick Ratio27.10 Sales past 5Y18.00% Gross Margin- 52W Low41.50% ATR2.54
Employees5 Current Ratio27.10 Sales Q/Q14.10% Oper. Margin- RSI (14)41.12 Volatility3.52% 4.40%
OptionableNo Debt/Eq0.00 EPS Q/Q10.50% Profit Margin- Rel Volume0.46 Prev Close56.17
ShortableYes LT Debt/Eq0.00 EarningsMay 08 Payout- Avg Volume68.74K Price57.42
Recom- SMA20-3.39% SMA50-9.78% SMA200-7.98% Volume18,806 Change2.23%
Nov-13-17Reiterated H.C. Wainwright Buy $72 → $65
Mar-08-16Initiated Rodman & Renshaw Buy $60
Jul-16-15Initiated MLV & Co Buy $76
Nov-11-14Reiterated MKM Partners Buy $38 → $46
Aug-12-14Reiterated MKM Partners Buy $28 → $38
Jan-09-14Reiterated MKM Partners Buy $24.50 → $28
Dec-09-13Reiterated MKM Partners Buy $23.50 → $24.50
Apr-05-12Initiated MKM Partners Buy $26.50
Mar-15-12Initiated Stifel Nicolaus Buy $29
Jun-15-09Initiated Hapoalim Outperform $40
May-23-19 08:01AM  BioSpecifics Technologies Corp. Announces Authorization of up to $4 Million Stock Repurchase Program PR Newswire
May-16-19 04:35PM  ImmunoGen Plunges as FDA Recommends New Study for Lead Drug Zacks
May-14-19 02:36PM  Catalyst (CPRX) Q1 Loss Narrows, Firdapse Off to a Good Start Zacks
May-12-19 10:00PM  Hedge Funds Have Never Been More Bullish On BioSpecifics Technologies Corp. (BSTC) Insider Monkey
May-10-19 08:26AM  BioSpecifics: 1Q Earnings Snapshot Associated Press
May-02-19 02:34PM  Zoetis (ZTS) Earnings Beat Estimates in Q1, Revenues Miss Zacks
Apr-30-19 08:02AM  What's in Store for BioSpecifics (BSTC) This Earnings Season? Zacks
Apr-16-19 07:17PM  Achaogen (AKAO) Files for Bankruptcy, Shares Plunge 65% Zacks
Apr-12-19 09:45AM  Weekly Jobless Claims Lowest in Nearly 50 Years: 5 Top Picks Zacks
Apr-09-19 10:29AM  Zogenix Gets Refusal to File Letter From FDA for Seizure Drug Zacks
10:06AM  United Therapeutics Discontinues PAH Drug After Study Fails Zacks
08:45AM  3 Reasons Why BioSpecifics (BSTC) Is a Great Growth Stock Zacks
Apr-04-19 09:10AM  5 Stocks With Recent Price Strength Despite Market Volatility Zacks
Apr-02-19 08:22AM  BioSpecifics: 4Q Earnings Snapshot Associated Press +5.47%
08:01AM  BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2018 Financial Results PR Newswire
Mar-25-19 08:32AM  Zacks.com featured expert Kevin Matras highlights: Darden Restaurants, Best Buy, BioSpecifics Technologies and ONEOK Zacks
Mar-22-19 08:01AM  4 Top Stocks to Buy for Superb Earnings Growth Zacks
Mar-20-19 09:00AM  BioSpecifics (BSTC) Upgraded to Strong Buy: Here's What You Should Know Zacks
Mar-18-19 08:01AM  BioSpecifics Technologies Corp. Announces Passing of President Thomas L. Wegman PR Newswire
Mar-05-19 04:36PM  What's in Store for BioSpecifics (BSTC) This Earnings Season? Zacks
Feb-21-19 11:27AM  Is BioSpecifics Technologies Corp. (NASDAQ:BSTC) A Volatile Stock? Simply Wall St.
Feb-04-19 07:35AM  Analysis: Positioning to Benefit within Amarin, Retrophin, Sunrun, BioSpecifics Technologies, Arbutus Biopharma, and TOCAGEN INC Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire +5.83%
Jan-28-19 09:32AM  BioSpecifics (BSTC) Upgraded to Buy: Here's What You Should Know Zacks
Jan-17-19 09:30AM  Is BioSpecifics Technologies (BSTC) Stock Outpacing Its Medical Peers This Year? Zacks
Jan-16-19 10:36AM  Is BioSpecifics Technologies Corp.s (NASDAQ:BSTC) Balance Sheet Strong Enough To Weather A Storm? Simply Wall St.
Jan-11-19 10:32AM  Ocular (OCUL) Submits an sNDA for Eye Pain Drug Dextenza Zacks
Jan-10-19 11:00AM  INSYS Therapeutics Rises on Dose-Ranging Allergy Study Data Zacks
08:43AM  Weakness Seen in Champions Oncology (CSBR) Estimates: Should You Stay Away? Zacks
Jan-09-19 09:45AM  Karyopharm Files MAA for Myeloma Candidate Selinexor in EU Zacks
Jan-07-19 12:42PM  Neurocrine Gives Ingrezza Sales View, Updates on Pipeline Zacks
Jan-03-19 10:29AM  Spectrum Pharma Fully Enrolls 1St Cohort in Poziotinib Study Zacks
10:26AM  Flexion Starts Phase III Enrollment on Zilretta for Hip OA Zacks
Jan-02-19 09:25AM  Portola Up as Large-Scale Andexxa Production Gets FDA Nod Zacks
Dec-28-18 09:45AM  Spectrum Pharma Files BLA for Neutropenia Candidate Rolontis Zacks
Dec-25-18 09:30AM  Is BioSpecifics Technologies (BSTC) Outperforming Other Medical Stocks This Year? Zacks
Dec-19-18 03:09PM  Small Drug Stocks Near-Term Outlook Positive, Despite Headwinds Zacks
Dec-17-18 10:29AM  Heres What BioSpecifics Technologies Corp.s (NASDAQ:BSTC) P/E Is Telling Us Simply Wall St.
Dec-12-18 10:15AM  Portola (PTLA) Down as CHMP Defers Review Date for Ondexxya Zacks
Dec-11-18 05:44PM  Jazz (JAZZ) Increases Share Buyback Authorization by $400M Zacks
09:22AM  Novan Announces Top-Line Data From Mid-Stage Molluscum Study Zacks
08:40AM  Why Tilray (TLRY) Could Be Positioned for a Slump Zacks
Dec-06-18 08:46AM  Should You Get Rid of Aerie Pharmaceuticals (AERI) Now? Zacks
Nov-29-18 04:47PM  Theravance Pipeline Strong, Plans Yupelri Launch by Year End Zacks
Nov-28-18 10:20AM  Theravance's Respiratory Disease JAK Inhibitor Enters Phase I Zacks
08:15AM  Market Trends Toward New Normal in Amarin, BioSpecifics Technologies, Cavco Industries, Iconix Brand Group, A-Mark Precious Metals, and Core-Mark Holding Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Nov-27-18 01:26PM  Is BioSpecifics Technologies Corp. (NASDAQ:BSTC) Worthy of Your Portfolio? Insider Monkey
Nov-21-18 11:15AM  Theravance JAK Inhibitor Enters Phase II for Crohn's Disease Zacks
09:58AM  IntelGenx's NDA Resubmission for Rizaport Gets FDA Acceptance Zacks
Nov-20-18 04:25PM  IBD Stock Of The Day Breezes Toward Breakout On New Inhaler Uses Investor's Business Daily
08:45AM  Galmed Pharmaceuticals (GLMD) in Focus: Stock Moves 6.2% Higher Zacks
08:33AM  TESARO (TSRO) Jumps: Stock Rises 5.4% Zacks
Nov-15-18 04:30PM  BioSpecifics Technologies Corp. Appoints Ron Law, Ph.D, J.D., as Senior Vice President of Business Development PR Newswire
02:15PM  Managers Of This Fund Like The Outlook For Small-Cap Stocks Investor's Business Daily
12:35PM  Is BioSpecifics Technologies Corp (NASDAQ:BSTC) Excessively Paying Its CEO? Simply Wall St.
Nov-09-18 09:20AM  BioSpecifics Technologies (BSTC) Q3 Earnings and Revenues Beat Estimates Zacks
08:13AM  BioSpecifics: 3Q Earnings Snapshot Associated Press
08:01AM  BioSpecifics Technologies Corp. Reports Third Quarter 2018 Financial Results PR Newswire
Nov-06-18 10:31AM  What's in the Cards for BioSpecifics (BSTC) in Q3 Earnings? Zacks
Nov-02-18 10:30AM  BioSpecifics Technologies (BSTC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
Oct-31-18 04:30PM  BioSpecifics Technologies Corp. Announces Positive Topline Results from Phase 1 Study of CCH for the Treatment of Uterine Fibroids PR Newswire
Oct-25-18 04:36PM  IBD Stock Of The Day Outperforms Biotech Sector In A Rough October Investor's Business Daily
Oct-19-18 08:45AM  Investor Expectations to Drive Momentum within Ultrapar Participacoes S.A, BioSpecifics Technologies, GSV Capital, 58, Mitel Networks, and Amarin Discovering Underlying Factors of Influence GlobeNewswire
Oct-09-18 10:01AM  Affimed Down After Clinical Hold on Two Early-Stage Studies Zacks
Oct-08-18 09:44AM  Zacks.com highlights: OptimizeRX, Verso, BioSpecifics Technologies and Luxfer Holdings Zacks
Oct-05-18 08:56AM  BioLineRx (BLRX) in Focus: Stock Moves 7.5% Higher Zacks
08:40AM  Champions Oncology (CSBR) Soars: Stock Adds 10.7% in Session Zacks
07:48AM  4 Stocks With Recent Price Strength to Maximize Your Gains Zacks
Oct-03-18 08:40AM  Infinity Pharmaceuticals (INFI) Looks Good: Stock Adds 6.5% in Session Zacks
Oct-02-18 09:40AM  Is BioSpecifics Technologies (BSTC) Stock Outpacing Its Medical Peers This Year? Zacks
Oct-01-18 11:38AM  Endo Recalls 2 Lots of Robaxin Tablets Due to Labeling Error Zacks
Sep-28-18 10:06AM  Aldeyra Therapeutics (ALDX) Looks Good: Stock Adds 7.5% in Session Zacks
Sep-27-18 09:12AM  Aldeyra Surges on Positive Dry Eye Study Data on Reproxalap Zacks
08:35AM  Adamis Pharmaceuticals (ADMP) in Focus: Stock Moves 8% Higher Zacks
Sep-26-18 11:14AM  Portola's (PTLA) Lymphoma Candidate Gets Orphan Drug Status Zacks
Sep-24-18 02:13PM  Why BioSpecifics Technologies Corps (NASDAQ:BSTC) ROE Of 15.7% Does Not Tell The Whole Story Simply Wall St.
Sep-20-18 11:40AM  Molecular Templates Surges 50%, Inks Cancer Deal With Takeda Zacks
07:37AM  Zacks.com highlights: Champions Oncology, STAAR Surgical, Boingo Wireless, Verso and BioSpecifics Technologies Zacks
Sep-19-18 07:48AM  5 Stocks With Recent Price Strength to Strengthen Portfolio Zacks
Sep-18-18 11:18AM  United Therapeutics In-Licenses Rights to IPF Candidate Zacks
Sep-11-18 08:51AM  Tilray (TLRY) Looks Good: Stock Adds 8.5% in Session Zacks
07:11AM  The Zacks Analyst Blog Highlights: AeroVironment, BioSpecifics, Codexis, Avid and American Outdoor Zacks
Sep-10-18 09:23AM  5 Top-Ranked Nasdaq Stocks Defying the Worst September Start Zacks
Sep-07-18 08:57AM  Spectrum Pharmaceuticals (SPPI) Catches Eye: Stock Jumps 5.7% Zacks +6.33%
Sep-06-18 08:57AM  Tesaro (TSRO) Surges: Stock Moves 5.5% Higher Zacks
08:38AM  What Makes Taro Pharmaceutical (TARO) a Strong Sell? Zacks
Sep-05-18 04:44PM  Biogen Begins Phase III Study on Ischemic Stroke Candidate Zacks
09:24AM  Zacks.com highlights: Verso, Johnson Outdoors, BioSpecifics Technologies and Luxfer Holdings Zacks
Sep-04-18 07:27AM  4 Stocks With Recent Price Strength to Maximize Your Gains Zacks
Aug-30-18 08:33AM  Affimed (AFMD) Soars: Stock Adds 10.8% in Session Zacks
08:01AM  BioSpecifics Technologies Corp. to Present at Two Upcoming September Conferences PR Newswire
Aug-28-18 10:27AM  Esperion (ESPR) Combination Regimen Lowers Bad Cholesterol Zacks
Aug-27-18 09:56AM  Portola Pharmaceuticals (PTLA) Jumps: Stock Rises 9.1% Zacks
09:27AM  Jazz's (JAZZ) Leukemia Drug Vyxeos Gets Approval in Europe Zacks
Aug-22-18 09:54AM  Ironwood's Linzess Gets Approval in Japan for New Indication Zacks
09:07AM  VIVUS' (VVUS) Qsymia Falters in a Highly Competitive Market Zacks
Aug-21-18 04:01PM  IBD Stock Of The Day: Vertex Pharma Nears Third Breakout Of 2018 Investor's Business Daily
10:09AM  Lannett Set to Lose Distribution Agreement With Key Supplier Zacks
08:20AM  Market Trends Toward New Normal in Addus HomeCare, Sandstorm Gold, BioSpecifics Technologies, Itau Unibanco Holding S.A, Akers Biosciences, and Kosmos Energy Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Aug-20-18 08:48AM  Zacks.com highlights: PCM, STAAR Surgical, Verso, Johnson Outdoors and BioSpecifics Technologies Zacks
Aug-17-18 06:49AM  5 Stocks With Recent Price Strength to Enhance Your Returns Zacks
BioSpecifics Technologies Corp., a biopharmaceutical company, engages in the development of an injectable collagenase clostridium histolyticum for various indications in the United States and internationally. The company offers injectable collagenase for the treatment of Dupuytren's contracture and Peyronie's disease under the XIAFLEX or Xiapex brands. It also provides injectable collagenase to treat frozen shoulder, cellulite, canine lipoma, lateral hip fat, plantar fibromatosis, and human lipoma, as well as uterine fibroids. In addition, the company engages in the development of other clinical indications for which collagenase injection has been tested, such as keloids, hypertrophic scars, scarred tendons, glaucoma, herniated intervertebral discs, and as an adjunct to vitrectomy. BioSpecifics Technologies Corp. has a development and license agreement with Endo Global Ventures. The company was founded in 1957 and is headquartered in Lynbrook, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chao Jennifer MDirectorJun 07Sale58.5545926,87430Jun 10 06:18 PM
Chao Jennifer MDirectorJun 05Sale57.882,911168,487489Jun 06 04:45 PM
Chao Jennifer MDirectorJun 04Sale56.562,600147,0563,400Jun 06 04:45 PM
CALDWELL PATRICK MPrincipal Financial OfficerJun 03Sale58.806,000352,8000Jun 05 01:50 PM
Chao Jennifer MDirectorMay 29Sale60.743,313201,2326,000Jun 03 11:00 AM
Wegman Mark NDirectorMay 24Sale61.097,800476,50265,272May 28 07:10 PM
Mattila JyrkiDirectorMay 22Option Exercise38.4818,750721,42519,126May 24 07:23 PM
Chao Jennifer MDirectorMay 22Option Exercise37.648,000301,1209,313May 23 05:34 PM
Mattila JyrkiDirectorMay 22Sale62.0618,7501,163,625376May 24 07:23 PM
Wegman Mark NDirectorMay 22Sale63.701,20076,44073,072May 23 05:13 PM
Wegman TobyDirectorMay 21Sale64.065,500352,353945,073May 22 03:46 PM
Wegman Mark NDirectorMay 21Sale64.046,000384,23674,272May 22 02:51 PM
Chao Jennifer MDirectorMay 17Sale63.724,000254,8601,313May 21 09:46 PM
Chao Jennifer MDirectorMay 16Option Exercise37.645,313199,9815,313May 21 04:06 PM
Wegman Mark NDirectorMay 15Option Exercise20.9515,000314,25080,272May 17 05:47 PM
Gitman PaulDirectorMay 15Sale65.835,000329,15015,000May 17 03:13 PM
Wegman Mark NDirectorSep 11Sale58.661,00058,65565,272Sep 11 09:23 PM
Wegman Mark NDirectorSep 10Sale57.315,500315,20666,272Sep 11 09:23 PM
Gitman PaulDirectorSep 07Sale57.641,00057,63720,000Sep 07 05:31 PM
Schamroth MichaelDirectorAug 29Option Exercise20.0015,000300,00099,000Aug 30 05:36 PM
Gitman PaulDirectorAug 29Sale49.795,000248,97320,000Aug 29 04:20 PM
Gitman PaulDirectorAug 28Sale48.885,000244,41625,000Aug 29 04:20 PM
Gitman PaulDirectorAug 27Sale50.1110,000501,14430,000Aug 29 04:20 PM
Gitman PaulDirectorAug 24Sale51.096,400326,96240,000Aug 27 08:35 PM
Wegman Mark NDirectorAug 23Sale52.564,698246,92971,772Aug 23 08:36 PM
Gitman PaulDirectorAug 23Sale51.275,425278,16646,400Aug 27 08:35 PM
Wegman Mark NDirectorAug 22Sale52.713,802200,39376,470Aug 23 08:36 PM
Estate of Edwin H. Wegman10% OwnerAug 17Sale51.892,500129,728947,473Aug 17 07:50 PM
Wegman ThomasPresidentAug 17Sale51.892,500129,728947,473Aug 17 07:47 PM
Wegman TobyDirectorAug 17Sale51.892,500129,728947,473Aug 17 07:48 PM
Wegman ThomasPresidentAug 16Sale51.2321,0921,080,566291,327Aug 17 07:47 PM
Wegman ThomasPresidentAug 15Sale50.007,921396,056312,419Aug 15 09:02 PM
Wegman ThomasPresidentAug 14Sale51.2115,987818,646320,340Aug 15 09:02 PM